News Center

Home page

Peak Report

News reports

Jianfeng Group Lin2016 -028 (Announcement on Acceptance Notice of Drug Clinical Trial Application of Subsidiary Company)

Release time:

2020-08-05

Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2016-028

Bond Abbreviation: 13 Peak 01 Bond Code: 122227

Bond Abbreviation: 13 Peak 02 Bond Code: 122344

Zhejiang Jianfeng Group Co., Ltd.

Announcement on Acceptance Notice of Subsidiary Drug Clinical Trial Application

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .

1. Summary

Recently, Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), a controlling subsidiary of the Company, received the Notice of Acceptance of Drug Registration Application (Acceptance No.: CXHL1600201 Zhejiang) and (Acceptance No.: CXHL1600202 Zhejiang) issued by Zhejiang Food and Drug Administration. The clinical research application of deoxypodophyllotoxin for injection (acceptance number: CXHL1600202 Zhejiang) and its bulk drug (acceptance number: CXHL1600201 Zhejiang) (hereinafter collectively referred to as "DPT") developed by Jianfeng Pharmaceutical and China Pharmaceutical University has been accepted by Zhejiang Food and Drug Administration.

2. drug basic information content

(I) deoxypodophyllotoxin

drug name: deoxypodophyllotoxin

dosage form: non-preparation: bulk drug

packing specification: 2Kg

per bag application item: chemical drug: class 1

Application Stage: Clinical

Applicant: Zhejiang Jianfeng Pharmaceutical Co., Ltd., China Pharmaceutical University

Application Acceptance Number: CXHL1600201 Zhejiang

Conclusion: After formal examination, the application materials basically meet the requirements of the "Measures for the Administration of Drug Registration" and other relevant regulations and are accepted. Approval is subject to review.

(II) Deoxypodophyllotoxin for Injection

Drug Name: Deoxypodophyllotoxin for Injection

Dosage Form: Preparation: Chinese Pharmacopoeia Dosage Form Injection

Specification: 100mg Package Specification: 1 bottle per box

Application Item: Chemical Drug: 1 Class

Application Stage: clinical

Applicant: Zhejiang Jianfeng Pharmaceutical Co., Ltd. and China Pharmaceutical University

Application Acceptance Number: CXHL1600202 Zhejiang

3. Drug Research and Development and Registration

DPT Project is a new anti-tumor drug developed by Jianfeng Pharmaceutical in cooperation with China Pharmaceutical University in March 112. Domestic and foreign listed alkaloids of similar drugs include: paclitaxel, vinorelbine. DPT indication/ function indication is tentatively designated as first-line and second-line treatment of lung cancer, breast cancer and gastric cancer; Especially for the treatment of the above tumors resistant to paclitaxel and vinorelbine.

DPT is currently in the stage of applying for clinical trial approval. After the clinical application of is accepted, the clinical research work can only be carried out after passing the review and approval of the State Food and Drug Administration (CFDA) and obtaining the clinical trial approval document. After the clinical trial is completed, the production can be applied, after passing the review and approval of CFDA and obtaining the drug production approval, can be produced and marketed.

Up to now, the accumulated research and development investment and other related expenditures of DPT project of Jianfeng Pharmaceutical Co., Ltd. are about 33 million yuan. The impact of

4. on listed companies and risk tips

DPT clinical application filed by the company has been accepted and will not have a significant impact on the company's recent operating results. After the clinical application of

is accepted, the clinical research work can only be carried out after passing the review and approval of CFDA and obtaining the clinical trial approval document. The results and time of the inspection, review and approval during the period are uncertain. Due to the long cycle and high risk of new drug research and development, the company will timely fulfill the obligation of information disclosure according to the progress of research and development. Please pay attention to the investment risk.

hereby announce

Zhejiang Jianfeng Group Co., Ltd. Board of Directors

August 25, 2016

More information

Company Leaders Attend Jinhua Development Conference

News from our newspaper On November 17, the second 2019 Jinhua Development Conference with the theme of "Insist on high-quality integration into the Yangtze River Delta to build a metropolitan area" opened in Jinhua, Zhejiang. More than a thousand people from the scientific and educational circles, business circles, and overseas Chinese from home and abroad Business people, representatives of "New Golden Chinese" and representatives of outstanding Jinhua students attended the meeting. Group leaders Jiang Xiaomeng, Yu Jianhong and Huang Jinlong attended the relevant activities of the conference. As a representative of the Jinhua business community, Jiang Xiaomeng, chairman of the group company, made a keynote speech at the "Scientist" and "Entrepreneur" Innovation Dialogue of the Development Conference, expressing his views on how Jinhua enterprises can improve their technological competitiveness. As the head of Jinhua local enterprise with a history of more than 60 years, Jiang Xiaomeng has a profound experience in promoting the development of enterprises through science and technology. Combined with the reality of peak scientific and technological innovation, he pointed out in his speech that the improvement of scientific and technological innovation ability is an urgent event for Jinhua small and medium-sized enterprises. Private enterprises cannot achieve high-quality development without the support of scientific and technological forces; with the progress of society, the improvement of people's living standards and the continuous improvement of cultural quality, the demand for products and the pursuit of product quality have also undergone qualitative changes. Only products with scientific and technological connotations can attract consumers. He suggested that the government and relevant institutions should establish an information platform to further understand the scientific and technological support that enterprises need in the transformation, understand what kind of help scientific and technological personnel can provide to enterprises, do a good job in the information docking of scientists and entrepreneurs, further attract investment and wisdom, give full play to the scientific and technological achievements of academicians and experts and the capital advantages of businessmen at home and abroad, and promote Jinhua enterprises to better integrate into Changsan

2020

07-30

Spike Nineteen Awarded "Celebrating the 70th Anniversary of the the People's Republic of China" Commemorative Medals

News from our newspaper Before the National Day, the Central Committee of the Communist Party of China, the State Council, and the Central Military Commission jointly issued the "Celebrating the 70th Anniversary of the Founding of the the People's Republic of China" commemorative medal. 19 veteran comrades including former chairman Du Zihong won this honor. It is understood that the "Celebrating the 70th Anniversary of the Founding of the the People's Republic of China" commemorative medals are awarded to eligible persons among the following objects: veterans and comrades who participated in the revolutionary work before the establishment of the the People's Republic of China; after the establishment of the the People's Republic of China, they have won national commendations and awards and above honors and are still alive. After the establishment of the the People's Republic of China, military personnel (including veterans) who have won first-class awards and are still alive; international friends who have made outstanding contributions to the establishment of the the People's Republic of China; those who died after January 1, 2019 are within the scope of this issuance. The issuance of the "Celebrating the 70th Anniversary of the Founding of the People's Republic of China China" commemorative medal is an important part of the series of celebrations for the 70th anniversary of the founding of New China. It is important for strengthening patriotism education, cultivating and practicing the core values of socialism, and enhancing the cohesion and appeal of the great cause of socialism with Chinese characteristics., Has a very important meaning. Among the 19 people who won the commemorative medals, Zheng Yunya, Xu Zeng, Wu Bingyin, Wang Zhendong, Gao Changxuan, Shi Gao, Zhou Zucheng, and Lu Weitang were retired cadres who took part in revolutionary work before the founding of New China, and Huang Jingui, Mou Dehua, and Zhang Wancai were old workers who took part in the work before the founding of New China, du Zihong, Fang Lianbai, Feng Hanwei, Tang Yanru, Wang Xinghua, Huang Shaobao, Huang Xiehe, etc. made outstanding contributions to national construction after the founding of New China and won

2020

07-31

Pinnacle International Trade Hosts Cotton Spinning Forum

In order to better play the role of cotton yarn futures delivery warehouse and promote the development of textile industry in the region, on September 24, peak international trading company and earth futures co., ltd. jointly held a "talk on cotton 2019-earth peak forum". With the theme of "Market Trends and Prospects of Cotton Textile Industry", the forum gathered more than 70 people from Hangzhou, Shaoxing, Shanghai, Lanxi, Changzhou, Jiangyin, Nantong and other parts of the country, as well as India and Vietnam, to seek common development plans for the cotton spinning industry. After obtaining the qualification of the designated cotton yarn delivery warehouse of Zhengzhou Commodity Exchange, the peak international trade actively implemented the work of the cotton yarn delivery warehouse. Hosting this forum is an important link for Jianfeng International Trade to start the cotton yarn delivery warehouse business. It aims to build an exchange platform for the cotton spinning industry, deeply study the operation rules of cotton yarn futures, enable textile mills, weaving mills and cotton yarn traders to quickly understand the Jianfeng warehouse and cotton yarn futures delivery and storage business, and jointly discuss the development trend of the cotton textile industry. Yu Jianhong, general manager of the group company, attended the meeting and delivered a speech. He expressed his gratitude and welcome to the guests who came to the forum, and said that Jinhua is located in the heart of Zhejiang, and its subordinate Lanxi City is China's main cotton textile industry base. The second pillar industry of Yiwu City is also the knitting industry. The demand for cotton yarn is huge. Peak International Trade to obtain cotton yarn futures delivery qualification, not only for Lanxi, Yiwu cotton textile industry and upstream and downstream merchants nearby to provide cotton yarn spot storage and futures delivery sites, but also can effectively serve this, service the province, and radiation to Jiangxi, Fujian and East China and other places. This forum

2020

07-31

Pinnacle International Trade Hosts Cotton Spinning Forum

2020

07-31

Pinnacle International Trade Hosts Cotton Spinning Forum

2020

07-22

Pinnacle International Trade Hosts Cotton Spinning Forum

2020

07-30

< 1...27 28 29...61 > 跳转到页